Aducanumab: A Deep Dive into BIIB037 and its Impact A compound, previously known as BIIB037, is a complex attempt to treat emerging Alzheimer's disease. Created by Biogen, the treatment functions by removing https://www.targetmol.com/compound/aducanumab